SIGLEC1 and neoplasm: Included confounders taken into account were: age, nodal status, tumor size, Ki67, receptor status (ER, PR, HER2), Tregs presence, TLLS (CD20+/CD3+) presence and CD169+ macrophage presence (Figures S3 and S4).